Literature DB >> 6606114

T cell regulation of IgA immunoglobulin production in gut-associated lymphoid tissues.

H Kawanishi, W Strober.   

Abstract

To explore mechanisms of gut-mucosal IgA immune response, we have established Con A-induced cloned T cell lines originating from PP and spleen. These cloned cells expressed Thy-1.2+, Lyt-1+2-, Ia (I-A and I-E) and H-2 (K/D) surface antigens. Cloned T cells derived from PP were found to suppress LPS-induced IgM and IgG synthesis and secretion of co-cultured PP B cells; in addition, whereas the PP cloned T cells did not bring about IgA production, they did cause the appearance of large numbers of cells expressing sIgA. In contrast, cloned T cells derived from spleen had little or no effect on LPS-induced IgM synthesis and secretion by PP B cells; in addition, whereas they did suppress IgG production, they neither brought about IgA production nor the appearance of cells expressing sIgA. These studies provide evidence for the existence of a new type of T cell in PP, a switch T cell, which is able to induce B cells to undergo class-specific switches from IgM to IgA; the PP switch T cells appear to govern the pathway of DNA recombination (or RNA splicing) rather than cellular events resulting in terminal differentiation. Thus, these switch T cells are probably responsible for the fact that PP are a major source of mucosal IgA B cells. In additional studies, we show that post-switch IgA B cells, i.e. cells precultured with PP cloned T cells, have the capacity to undergo terminal differentiation into IgA producing plasma cells. provided they are exposed to helper T cells (uncloned) and an appropriate mitogenic stimulus (staphylococcal protein A). We can conclude, therefore, that the development of PP B cells into IgA-producing plasma cells in gut-associated lymphoid tissues (GALT) appears to require at least two steps: one which involves heavy chain switching to IgA and which is governed by IgA class-specific switch T cells in PP, and one which involves differentiation of post-switch B cells and which is governed by helper T cells in lymphoid tissues outside of PP (such as MLN and spleen).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606114     DOI: 10.1016/0161-5890(83)90034-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice.

Authors:  N Lycke; L Lindholm; J Holmgren
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

3.  Significance of different J chain profiles in human tissues: generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue.

Authors:  P Brandtzaeg; F R Korsrud
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

4.  Immunological abnormalities in the tonsils of patients with IgA nephropathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis.

Authors:  J Egido; R Blasco; L Lozano; J Sancho; R Garcia-Hoyo
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Immunocompetence of normal human appendiceal lymphoid cells: in vitro studies.

Authors:  H Kawanishi
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

6.  The CD4 Leu 8- T helper cell in colonic mucosa: a quantitative and functional analysis.

Authors:  R H Ming; R G Strickland; M Listrom; C Fenoglio-Preiser
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 7.  Functional macrophages and gastrointestinal disorders.

Authors:  Yue-Hong Liu; Yue Ding; Chen-Chen Gao; Li-Sheng Li; Yue-Xiu Wang; Jing-Dong Xu
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.